about
RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase.Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugsPro32Pro33 mutations in the integrin β3 PSI domain result in αIIbβ3 priming and enhanced adhesion: reversal of the hypercoagulability phenotype by the Src inhibitor SKI-606.Effect of Cordycepin-Enriched WIB801C from Cordyceps militaris Suppressing Fibrinogen Binding to Glycoprotein IIb/IIIaDelivery of Polymeric Nanoparticles to Target Vascular Diseases.Inhibitory Effects of Cytosolic Ca(2+) Concentration by Ginsenoside Ro Are Dependent on Phosphorylation of IP3RI and Dephosphorylation of ERK in Human Platelets.Inhibitory effects of total saponin from Korean Red Ginseng on [Ca(2+)]i mobilization through phosphorylation of cyclic adenosine monophosphate-dependent protein kinase catalytic subunit and inositol 1,4,5-trisphosphate receptor type I in human platAntiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.Total saponin from Korean Red Ginseng inhibits binding of adhesive proteins to glycoprotein IIb/IIIa via phosphorylation of VASP (Ser(157)) and dephosphorylation of PI3K and AktAntithrombotic effects of targeting alphaIIbbeta3 signaling in platelets.Vasodilator-stimulated phosphoprotein-phosphorylation by ginsenoside Ro inhibits fibrinogen binding to αIIb/β3 in thrombin-induced human platelets.Blood flow devices in medical research and clinical testing in humans: are we approaching personalized medicine?Advances in the monitoring of anti-P2Y12 therapy.A rare cause of chest pain in a cancer patient.Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability.Leucine-rich repeats 2-4 (Leu60-Glu128) of platelet glycoprotein Ibalpha regulate shear-dependent cell adhesion to von Willebrand factor.
P2860
Q30157707-379050BF-28C3-4747-BE50-FBE0D5010F2AQ30528515-AF6080FD-D43A-46DD-B37E-5818EF238843Q33584613-DCEDA395-407B-41A0-BF04-DE7846DF5BB5Q34865151-8EC4D75F-56A0-4A81-9225-8AF4ED77CA8AQ35701214-98B51FD7-57CC-4F66-B4EA-4374A0555C04Q36017567-8860482C-233E-441E-94E7-026785B9E197Q36122716-28D87B4D-DC92-463C-A052-E895C8BE186BQ36215337-001EC682-067E-4057-AA4B-815532038F96Q36437891-744FD9DB-54AF-4E7B-B0EC-F04906430C74Q37157980-CE72B049-3AFF-44EF-BEEF-66535AE04040Q37314349-54356545-A96B-4A89-8BBC-BA5BDF8840B0Q37608557-EAD208A2-4BF9-4673-AC28-430C4FA9384CQ38037121-4B0DB52D-BD5D-45AB-AB11-FCD66E26AC5FQ42852290-87C59F6B-130E-433D-83DD-B224E2512381Q46783687-A12EFA0F-57C1-4572-B36C-ECC703B0EFA4Q51204315-4C097224-A6AB-4E2D-A7EA-F841518B9AF1Q51806809-C04CE388-FD1B-4EB5-BF44-784492B4EC76
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Therapeutic approaches in arterial thrombosis
@ast
Therapeutic approaches in arterial thrombosis
@en
Therapeutic approaches in arterial thrombosis
@nl
type
label
Therapeutic approaches in arterial thrombosis
@ast
Therapeutic approaches in arterial thrombosis
@en
Therapeutic approaches in arterial thrombosis
@nl
prefLabel
Therapeutic approaches in arterial thrombosis
@ast
Therapeutic approaches in arterial thrombosis
@en
Therapeutic approaches in arterial thrombosis
@nl
P2093
P2860
P3181
P1476
Therapeutic approaches in arterial thrombosis
@en
P2093
P2860
P304
P3181
P356
10.1111/J.1538-7836.2005.01418.X
P407
P577
2005-08-01T00:00:00Z